It was demonstrated in previous studies that the Millettia erythrocalyx Gagnep has several biologically active compounds [17], in particular, compounds possessing anti-cancer capability against several cancer types [18,19], however, the CSC-targeting as well as Akt inhibition are largely under investigated. Here, AKT1 is linked to cancer.